Bayer Sells €3 Billion Stake in Contraceptives Division to Apollo
Bayer has sold a non-controlling minority stake of its contraceptive business, valued at €3 billion ($3.4 billion), to asset management firm Apollo. The deal allows Bayer to strengthen its capital structure and financial flexibility without relinquishing control over the long-acting reversible contraceptives (LARC) segment.
Tickers: $APO
Topics: Apollo Global Management capital structure contraceptives pharmaceuticals